Related Experiment Video
Updated: Feb 25, 2026

08:07
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
3.1K
[Bacterial outer membrane vesicles as nano carriers to study immunological activities]
Chen Qi1, W U Min1, Bai Hongzhen1
1Department of Chemistry, Zhejiang University, Hangzhou 310028, China.
Summary
Researchers developed a novel nano-carrier by combining bacterial outer membrane vesicles (OMV) with pluronic F127. This OMV-F127 formulation demonstrated significant immunological activity by stimulating cytokine secretion in immune cells.
Area of Science:
- Biotechnology
- Immunology
- Materials Science
Background:
- Bacterial outer membrane vesicles (OMV) are promising nanocarriers.
- Pluronic F127 is a biocompatible polymer often used in drug delivery.
- Combining OMV with polymers can enhance nanocarrier properties.
Purpose of the Study:
- To create a novel nano-carrier by integrating OMV with Pluronic F127 (OMV-F127).
- To evaluate the immunological activity and cytokine-inducing potential of the OMV-F127 nano-carrier.
Main Methods:
- OMV were isolated from attenuated Salmonella using centrifugal ultrafiltration or ultrasonication.
- OMV-F127 nano-carriers were fabricated via mechanical extrusion.
- Characterization involved BCA, SDS-PAGE, Field Emission Scanning Electron Microscopy (FM), Transmission Electron Microscopy (TEM), and Dynamic Light Scattering (DLS).
- Immunological activity was assessed by measuring IL-12, TNF-α, and IFN-γ secretion from mouse macrophage RAW264.7 cells stimulated with OMV-F127 using ELISA kits.
Main Results:
- Isolated OMV contained significant protein content (2.7-2.8 mg/mL) and marker proteins like OmpF/C.
- FM and TEM confirmed a spherical morphology for both F127 and OMV-F127.
- Particle size analysis showed OMV at 72±2 nm, F127 at 90±3 nm, and OMV-F127 at 92±2 nm.
- OMV-F127 treatment significantly elevated the secretion of IL-12, TNF-α, and IFN-γ in RAW264.7 cells.
Conclusions:
- A novel OMV-F127 nano-carrier was successfully prepared.
- The OMV-F127 nano-carrier exhibits potent immunomodulatory effects by stimulating cytokine production.
- This bacterial OMV-based nano-carrier holds potential for immunological applications.

